149 related articles for article (PubMed ID: 29718791)
1. Radioembolization in Advanced Hepatocellular Carcinoma.
Riaz A; Lewandowski R; Salem R
J Clin Oncol; 2018 Jul; 36(19):1898-1901. PubMed ID: 29718791
[TBL] [Abstract][Full Text] [Related]
2. Can Stereotactic Body Radiotherapy Effectively Treat Hepatocellular Carcinoma?
Barry A; Knox JJ; Wei AC; Dawson LA
J Clin Oncol; 2016 Feb; 34(5):404-8. PubMed ID: 26700118
[TBL] [Abstract][Full Text] [Related]
3.
Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer.
Rosenzweig KE; Gomez JE
J Clin Oncol; 2017 Jan; 35(1):6-10. PubMed ID: 27870565
[TBL] [Abstract][Full Text] [Related]
5. Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Pagliaro LC
J Clin Oncol; 2017 Apr; 35(10):1036-1040. PubMed ID: 27992270
[TBL] [Abstract][Full Text] [Related]
6. Which Patients With Cervical Squamous Cell Carcinoma Might Benefit From Neoadjuvant Chemotherapy?
Mahmoud O; Einstein MH
J Clin Oncol; 2018 Jun; 36(16):1543-1547. PubMed ID: 29668367
[TBL] [Abstract][Full Text] [Related]
7. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Gilligan T
J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
[TBL] [Abstract][Full Text] [Related]
8. Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
Kokabi N; Camacho JC; Xing M; El-Rayes BF; Spivey JR; Knechtle SJ; Kim HS
Cancer; 2015 Jul; 121(13):2164-74. PubMed ID: 25847227
[TBL] [Abstract][Full Text] [Related]
9. Optimizing Treatment Risk and Benefit for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Right Treatment for the Right Patient.
Presley CJ; Gross CP; Lilenbaum RC
J Clin Oncol; 2016 May; 34(13):1438-42. PubMed ID: 27001591
[TBL] [Abstract][Full Text] [Related]
10. Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe.
Kollmannsberger CK; Nappi L; Nichols C
J Clin Oncol; 2019 Aug; 37(22):1856-1862. PubMed ID: 31180818
[No Abstract] [Full Text] [Related]
11. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
13. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
Khushalani NI
J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
[TBL] [Abstract][Full Text] [Related]
14. Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?
Mehta MP; Kotecha R
J Clin Oncol; 2018 Oct; ():JCO2018793232. PubMed ID: 30296192
[TBL] [Abstract][Full Text] [Related]
15. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
Sangro B; Carpanese L; Cianni R; Golfieri R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Van Buskirk M; Bilbao JI; Ettorre GM; Salvatori R; Giampalma E; Geatti O; Wilhelm K; Hoffmann RT; Izzo F; Iñarrairaegui M; Maini CL; Urigo C; Cappelli A; Vit A; Ahmadzadehfar H; Jakobs TF; Lastoria S;
Hepatology; 2011 Sep; 54(3):868-78. PubMed ID: 21618574
[TBL] [Abstract][Full Text] [Related]
16. Optimization of Risk Stratification in Localized Prostate Cancer.
Morgans AK
J Clin Oncol; 2018 Feb; 36(6):528-532. PubMed ID: 29303624
[TBL] [Abstract][Full Text] [Related]
17. Incorporating Androgen Deprivation With Dose-Escalated External-Beam Radiotherapy for Prostate Cancer.
Dosoretz AP; Yu JB
J Clin Oncol; 2016 May; 34(15):1718-22. PubMed ID: 27001587
[TBL] [Abstract][Full Text] [Related]
18. Management of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer.
Rusthoven CG; Doebele RC
J Clin Oncol; 2016 Aug; 34(24):2814-9. PubMed ID: 27298405
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Radiotherapy: An Evolving Paradigm.
Catton CN; Lukka H; Martin J
J Clin Oncol; 2018 Oct; 36(29):2909-2913. PubMed ID: 30138084
[TBL] [Abstract][Full Text] [Related]
20. When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.
Perez K; Clancy TE; Mancias JD; Rosenthal MH; Wolpin BM
J Clin Oncol; 2017 Feb; 35(5):485-489. PubMed ID: 28029328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
